InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Dimitris Voliotis
20 Jan 2022
SVP, Clinical Development
Sold after exercise
1,657
$61.21
$101.42K
Dimitris Voliotis
20 Jan 2022
SVP, Clinical Development
Sold after exercise
8,343
$60.52
$504.90K
Dimitris Voliotis
19 Jan 2022
SVP, Clinical Development
Sold after exercise
555
$62.24
$34.54K
Dimitris Voliotis
19 Jan 2022
SVP, Clinical Development
Sold after exercise
1,556
$61.51
$95.71K
Dimitris Voliotis
19 Jan 2022
SVP, Clinical Development
Sold after exercise
7,889
$60.55
$477.68K
Dimitris Voliotis
18 Jan 2022
SVP, Clinical Development
Sold after exercise
1,300
$64.66
$84.06K
Dimitris Voliotis
18 Jan 2022
SVP, Clinical Development
Sold after exercise
1,997
$63.48
$126.77K
Dimitris Voliotis
18 Jan 2022
SVP, Clinical Development
Sold after exercise
3,294
$62.34
$205.33K
Dimitris Voliotis
18 Jan 2022
SVP, Clinical Development
Sold after exercise
3,409
$61.70
$210.33K
Kimberly Blackwell
3 Jan 2022
Director
Sold after exercise
1,000
$83.74
$83.74K
Kimberly Blackwell
1 Dec 2021
Director
Sold after exercise
1,000
$81.84
$81.84K
Kimberly Blackwell
1 Nov 2021
Director
Sold after exercise
1,000
$80.46
$80.46K
Alexis Pinto
25 Oct 2021
Chief Legal Officer
Sold after exercise
300
$78.85
$23.66K
Alexis Pinto
25 Oct 2021
Chief Legal Officer
Sold after exercise
19,802
$78.05
$1.55M
Alexis Pinto
25 Oct 2021
Chief Legal Officer
Sold after exercise
8,098
$77.27
$625.73K
Alexis Pinto
25 Oct 2021
Chief Legal Officer
Sold after exercise
1,800
$76.10
$136.97K
Kimberly Blackwell
25 Oct 2021
Director
Sold after exercise
1,000
$77.59
$77.59K
Showing 250 of 464 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 221
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 17
Sales at will 414
Transactions with no price 0
Shares from compensation/vesting 12,076,610
Sales filed before the plan box existed 397
History held since 8 Apr 2020